Charles River Laboratories (CRL) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
February 16, 2022 7:00 AM ESTFourth-Quarter Revenue of $905.1 Million and Full-Year Revenue of $3.54 Billion
Fourth-Quarter GAAP Earnings per Share of $2.67 and Non-GAAP Earnings per Share of $2.49
Full-Year GAAP Earnings per Share of $7.60 and Non-GAAP Earnings per Share of $10.32
Reaffirms 2022 Guidance
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2021 and reaffirmed guidance for 2022. For the quarter, revenue was $905.1 million, an increase of 14.4% from $791.0 million in the fourth quarter of 2020.
Acquisitions contributed 5.9% to... More
